Clinical Study
Short-Term Neurodevelopmental Outcome in Term Neonates Treated with Phenobarbital versus Levetiracetam: A Single-Center Experience
| Source | Study type | Population | Gender distribution | Primary LEV | Secondary LEV | Loading dose | Maintenance dose | Other AED |
| Hmaimess et al. (2006) | Case report | Term neonate | 1M | 0 | 1 | 10 mg/kg | 30 mg/kg | PHT, CLZ, PB, MDZ, LMT | Shoemaker and Rotenberg (2007) | Case report | Preterm/term | 1F/2M | 0 | 3 | 60 mg/kg | 30 mg/kg | PB, PHT, MDZ | Abend et al. (2011) | Retrospective | Preterm/term neonates | 11M/12F | 4 | 19 | 10-20 mg/kg | 5-40 mg/kg | PB, PHT, TPM, MDZ, FA | Ramantani et al. (2011) | Prospective | Preterm/term neonates | 24M/14F | 38 | 0 | 10 mg/kg | Up to 60 mg/kg | Up to 2 doses of PB 20 mg/kg | Khan et al. (2011) [43] | Retrospective | Term neonates | 10M/12F | 3 | 19 | 10-50 mg/kg | 25 mg/kg | PB, FP, LZP, MDZ | Khan et al. (2013) | Retrospective | Preterm neonates | 4M/7F | 3 | 8 | 25-50 mg/kg | 25 mg/kg | PB | Rakshasbhuvankar et al. (2013) | Case series | Preterm/term neonates | 5M/3F | 0 | 8 | 5-10 mg/kg | 10-35 mg/Kg | PB, CZP, TPM, OXC | Yau et al. (2015) | Retrospective | Preterm/term neonates | ā | 0 | 12 | 7-20 mg/kg | 5-60 mg/kg | PHT, TPM | Falsaperla et al. (2017) | Prospective | Preterm/term neonates | ā | 16 | 0 | 10 mg/kg | Up to 40 mg/kg | PB |
|
|
Legend: CLZ: clonazepam; FA: folinic acid; FP: fosphenytoin; LZP: lorazepam; MDZ: midazolam; OXC: oxcarbazepine; PB: phenobarbital; PHT: phenytoin; TPM: topiramate.
|